`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`
`ARGENTUM PHARMACEUTICALS LLC
`
`Petitioner
`
`v.
`
`CIPLA LIMITED
`
`Patent Owner
`
`_____________________
`
`Case No. IPR2017-00807
`
`U.S. Patent No. 8,168,620
`_____________________
`
`CIPLA LIMITED’S UPDATED MANDATORY NOTICES
`
`
`
`
`
`
`
`
`
`
`
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`
`
`
`Cipla Ltd.’s Updated Mandatory Notices
`IPR2017-00807
`Patent Owner, Cipla Limited, hereby files updated mandatory notices
`
`
`
`
`
`pursuant to 37 C.F.R. § 42.8(a)(2).
`
`A. Related Matters (37 C.F.R. § 42.8(b)(2))
`
`Patent Owner’s previously identified related matters: (1) Meda Pharms. Inc.
`
`v. Apotex Inc., 14-cv-01453 (D. Del.); (2) Meda Pharms. Inc. v. Teva Pharms., 15-
`
`cv-00785 (D. Del.); and (3) Meda Pharms. Inc. v. Perrigo UK Finco Ltd., 16-cv-
`
`00794 (D. Del.), have been resolved.
`
`Patent Owner updates the status of the previously identified patent
`
`application assigned to Meda Pharmaceuticals Inc.:
`
`- U.S. Application No. 13/284,836 filed October 29, 2011 (abandoned;
`
`Petition for Revival filed April 6, 2018). Patent Owner does not concede that this
`
`application would affect, or be affected by, a decision in the present inter partes
`
`review of U.S. Patent No. 8,168,620.
`
`
`
`B.
`
`Lead and Back-Up Counsel (37 C.F.R. § 42.8(b)(3))
`
`Patent Owner designates the following lead and back-up counsel, updating
`
`their email addresses as follows:
`
`Lead Counsel: Dennies Varughese (Reg. No. 61,868) phone: 202.772.8805
`Back-up Counsel: Deborah A. Sterling (Reg. No. 62,732) phone: 202.772.8501
`Back-up Counsel: Adam C. LaRock (Reg. No. 64,681) phone: 202.772.8794
`Back-up Counsel: Uma N. Everett (admitted pro hac vice) phone: 202.772.8520
`
`- 1 -
`
`
`
`Cipla Ltd.’s Updated Mandatory Notices
`IPR2017-00807
`
`
`
`
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`1100 New York Avenue, NW
`Washington, DC 20005
`202.371.2600 (reception)
`202.371.2540 (facsimile)
`dvarughe-PTAB@sternekessler.com
` dsterling-PTAB@sternekessler.com
`
`alarock-PTAB@sternekessler.com
`
`ueverett-PTAB@sternekessler.com
`
`Service Information (37 C.F.R. § 42.8(b)(4))
`
`
`Address:
`
`
`
`
`
`
`
`
`
`
`C.
`
`Please direct all correspondence regarding this proceeding to the lead
`
`counsel and back-up counsel at the addresses listed above.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` Respectfully Submitted,
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`
`
`
`
`
`
`
`Dennies Varughese (Reg. No. 61,868)
`Lead Attorney for Patent Owner
`
`Date: April 24, 2018
`1100 New York Avenue, N.W.
`Washington, D.C. 20005-3934
`(202) 371-2600
`
`- 2 -
`
`
`
`CERTIFICATE OF SERVICE (37 C.F.R. §§ 42.6(e))
`
`
`
`
`
`
`
`
`The undersigned hereby certifies that the above-captioned “Cipla Limited’s
`
`Updated Mandatory Notices” was served in its entirety on April 24, 2018, upon the
`
`following parties via email:
`
`
`Michael R. Houston: mhouston@foley.com
`Joseph P. Meara: jmeara@foley.com
`James P. McParland: jmcparland@foley.com
`Andrew R. Cheslock: acheslock@foley.com
`Tyler C. Liu: TLiu@agpharm.com
`ARG-dymista@foley.com
`
`
`
`
`
`
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`
`
`
`Dennies Varughese (Reg. No. 61,868)
` Lead Attorney for Patent Owner
`
`Date: April 24, 2018
`1100 New York Avenue, N.W.
`Washington, D.C. 20005-3934
`(202) 371-2600
`
`
`
`
`
`
`
`
`
`